scorecardresearch
Add as a preferred source on Google
Thursday, September 25, 2025
TopicMedicines

Topic: Medicines

These 5 anti-viral drugs and therapies could help treat COVID-19

Researchers and pharmaceutical giants across the world are scrambling to find a cure for coronavirus which has been declared a pandemic.

What are APIs and how they threaten India’s status of a ‘pharmacy to the world’

Despite being a leading supplier of medicines to several countries, India is highly dependent on China for raw materials even to produce medicines as basic as Crocin.

Year after HC order, Modi govt to act against e-pharmacies selling drugs without licences

Quoting Delhi HC's December 2018 orders, India’s drug regulator has written to all states & UTs to take necessary action with respect to online sale of medicines.

Big Pharma has failed. It’s been 35 years since a new class of antibiotics entered the market

Antibiotics are among the most important medicines known to humankind, but we are running out of it.

Indians pay 70% less than the global median to buy medicines, study finds

A study compared the prices of drug compounds across the world and found that only Thailand, Kenya, Malaysia and Indonesia are cheaper than India.

Danish firm gets FDA approval for oral diabetes pill, no word yet on India launch

India has 7.2 crore people with diabetes and oral pills will help them avoid the pain of puncturing themselves again and again.

India again lobbies with Beijing to sell its generic medicines amid US-China trade war

Modi govt has asked China to provide quick clearances for made-in-India drugs at the India-China Strategic Economic Dialogue meet held between 7-9 September.

Why sale of Naloxone, a life-saving drug that reverses opioid overdose, is falling in India

Use of Naloxone in India has dropped by nearly half since 2014 — from 30,000 units to 15,700 units in 2018-2019.

To fix quality of Indian drugs, Modi govt plans to tighten transportation & storage laws

Govt has stepped up the process after recent controversies raised question marks on the quality of drugs being manufactured in India.

How Ranbaxy faked manufacturing data for all drugs not only in India, but in US, Europe too

Ranbaxy was treating data as an entirely fungible marketing tool, apparently without consideration of impact on patients. It was an outright fraud.

On Camera

Bads of Bollywood brought Emraan Hashmi out of our guilty pleasure closet, made him cool

With his cameo in Bads of Bollywood, Emraan Hashmi, who has long shifted away from his signature bold image, got the chance to revive his boyhood charm.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

‘Agni’ on the move—India successfully test-fires Agni-Prime nuclear missile from a train

With the latest test, India has the capability to launch a nuclear missile from under the sea, surface, air, and now from a railway network.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.